Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: Effect of acquisition time and implications for protocols

Journal of Computer Assisted Tomography

Volumn 29, Issue 1, 2005, Pages 59-63

  Goh, Vicky ^a,b   Halligan, Steve ^a   Hugill, Jo Ann ^a   Gartner, Louise ^a   Bartram, Clive I ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Colon; Computed tomography; Neoplasms; Perfusion study; Rectum

Indexed keywords

DISEASES; HEMODYNAMICS; MERGERS AND ACQUISITIONS; MULTIDETECTOR COMPUTED TOMOGRAPHY; TUMORS;

ACQUISITION TIME; BLOOD VOLUMES; COLON; COMPUTED TOMOGRAPHY; DYNAMIC CONTRAST-ENHANCED; MEAN TRANSIT TIME; NEOPLASM; PERFUSION MEASUREMENTS; PERFUSION STUDIES; RECTUM;

BLOOD;

ABDOMEN; ADULT; AGED; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; COLORECTAL CANCER; CONTRAST ENHANCEMENT; FEMALE; HUMAN; MALE; MEASUREMENT; MULTIDETECTOR COMPUTED TOMOGRAPHY; PERFUSION; PERMEABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TIME; TUMOR BLOOD FLOW;

EID: 13244277495     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000152847.00257.d7     Document Type: Article

References (24)

1. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radial. 2003;76:220-231.
2. World Health Organization. WHO Hand Book for Reporting Results of Cancer Treatment. WHO offset publication no. 48. Geneva: World Health Organization; 1979.
3. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205-216.
4. Li WW. Tumor angiogenesis: molecular pathology, therapeutic targeting and imaging. Acad Radiol. 2000;7:800-811.
5. Kabbinavar F, Hurwitz HI, Fehrenbacher L, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol. 2003;21:60-65.
6. Miles KA, Hayball M, Dixon AK. Colour perfusion imaging: a new application of computed tomography. Lancet. 1991;337:643-645.
7. Miles KA. Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol. 1991;64:409-412.
8. Axel L. Cerebral blood flow determination by rapid sequence computed tomography: theoretical analysis. Radiology. 1980;137:679-686.
9. Axel L. Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol. 1983;18:94-99.
10. Miles KA, Kelley BB. CT measurements of capillary permeability within nodal masses: a potential technique for assessing the activity of lymphoma. Br J Radiol. 1997;70:74-79.
11. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology. 1993;188:405-411.
12. Miles KA, Hayball MP, Dixon AK. Functional imaging of changes in human intrarenal perfusion using quantitative dynamic computed tomography. Invest Radiol. 1994;29:911-914.
13. Miles KA, Hayball MP, Dixon AK. Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. Br J Radiol. 1995;68:471-475.
14. Hoeffher EG, Case I, Jain R, et al. Cerebral perfusion CT: technique and clinical applications. Radiology. 2004;231:632-644.
15. Eastwood JD, Lev MH, Provenzale JM. Perfusion CT with iodinated contrast material. AJR Am J Roentgenol. 2003;180:3-12.
16. Harvey CJ, Blomley MJK, Dawson P, et al. Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience. J Comput Assist Tomogr. 2001;25:43-49.
17. Miles K, Dawson P, Blomley M. Functional Computed Tomography. Oxford, UK: Isis Medical Media; 1997.
18. Dugdale PE, Miles KA, Bunce I, et al. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. J Comput Assist Tomogr. 1999;23:540-547.
19. Kiessling F, Boese J, Corvinus C, et al. Perfusion CT in patients with advanced bronchial carcinoma: a novel chance for characterization and treatment monitoring. Eur Radiol. 2004;14:1226-1233.
20. Miles KA. Perfusion CT for the assessment of tumor vascularity: which protocol? Br J Radiol. 2003;76(Suppl 1):S36-S42.
21. Nabavi DG, Cenic A, Craen RA, et al. CT assessment of cerebral perfusion in man. Experimental validation and initial clinical experience. Radiology. 1999;213:141-149.
22. Bae KT, Tran HQ, Heiken JP. Uniform vascular contrast enhancement and reduced contrast medium volume achieved by using exponentially decelerated contrast medium injection method. Radiology. 2004;231:732-736.
23. Cenic A, Nabavi DG, Craen RA, et al. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral flow maps. AJR Am J Neuroradiol. 2000;21:462-470.
24. Molls M, Vaupel P. Blood Perfusion and Microenvironment of Human Tumors. Implications for Clinical Radiooncology. Berlin: Springer; 1998.